100
Participants
Start Date
October 31, 2002
Primary Completion Date
July 31, 2003
Study Completion Date
July 31, 2003
Ramelteon and Placebo (9 possible combinations total)
"Randomized sequence over two consecutive nights for a total of three treatment periods to include the following:~Ramelteon 4 mg, tablets, orally over two nights~Ramelteon 8 mg, tablets, orally over two nights~Ramelteon placebo-matching tablets, orally over two nights"
Hot Springs
Irvine
Palm Springs
San Diego
Brandon
Miami
Naples
Pembroke Pines
St. Petersburg
Atlanta
Overland Park
Crestview Hills
Troy
St Louis
Winston-Salem
Cincinnati
Toledo
Houston
Lead Sponsor
Takeda
INDUSTRY